Obama care a new opportunity in us healthcare - finpro
description
Transcript of Obama care a new opportunity in us healthcare - finpro
![Page 1: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/1.jpg)
ObamaCare - a new opportunity
in US Healthcare Market Opportunity Day 17.5.2013
Eero Toivainen, Finpro
![Page 2: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/2.jpg)
Healthcare and pharmaceuticals market in the US
• The US medical and healthcare
market is the single biggest market
in the world – the healthcare
expenditures comprise 47.5% of
the global expenditures
• The market is growing at almost a
10% rate and the share of
imported products and
technologies is 32% and rising.
• The US is also the center for
healthcare innovations as many of
the most successful healthcare
devices, practices and
technologies originate in the US
5/21/2013 © Finpro 2
![Page 3: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/3.jpg)
The Drivers of the Business Opportunity
• Healthcare reform (ObamaCare), a growing elderly population with an associated disease burden, changing regulatory guidelines, new drug launches, and a growing mobile and wellness sector are main drivers
– In order for to meet the future demand, the industry needs new ideas, technologies, and partners from abroad
– Many of the companies in the industry are investing in executive education and preparing new processes to learn how to work with European SMEs and start-ups
• The new healthcare mindset stems from healthcare reform (ObamaCare) and the necessity to cut costs and improve the quality of care
– Hospitals are now accountable and are being penalized for readmissions within 30 days.
– There is a new need for “hospital at home” and new easy to use home care solutions – prevention and mobile are growing
5/21/2013 3 © Finpro
![Page 4: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/4.jpg)
Healthcare Reform (ObamaCare)
• ObamaCare is aimed at reforming the American health care
system
• The objective is regulating the health insurance industry while
improving the quality of care and reducing costs
• New technologies, services, and mindset are needed –
American companies are looking outside for the solutions
• Total Health – the concept of integrating prevention, wellcare,
lifestyle and healthcare is creating a new opportunity for new
players
• ObamaCare will expand Medicaid and Medicare enabling
approximately 50 million new people to be insured, thereby
creating a need for new products and services
• ObamaCare will come into effect on 2014 and now is the time
to become involved in the industry
5/21/2013 4 © Finpro
![Page 5: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/5.jpg)
Healthcare and pharmaceuticals market in the US
5/21/2013 5 © Finpro
Hospital care 31 %
Physician and clinical services
20 %
Dental care 4 %
Nursing home and home health
8 %
Prescription drugs 10 %
Research, structures and equipment
investments 6 %
Other Items 21 %
Breakdown of the healthcare expenditures in the US by
category, 2011
Source: US Gov.
![Page 6: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/6.jpg)
Life Science Opportunities in the US
• Healthcare and medical devices
• Disease specific pharmaceuticals and biotechnology product
• Hospital equipment and operating room solutions
• Electronic medical data and HCI
• Exercise and wellness hardware, software and interfaces,
preventive medicine
• Personalized medicine
• Food and food additives.
5/21/2013 6 © Finpro
![Page 7: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/7.jpg)
Pharmaceuticals, medical devices and operating
room equipment
• Pharmaceutical market is a
several hundred billion dollar
business in the US
• Generic pharmaceuticals, a $53
billion dollar industry, is expected
to be one of the fastest-growing
sectors in the country with average
expected growth of 6.3% until
2017
• Medical devices, hospital and
operating room solutions and
equipment are also lucrative and
growing market segments
• Additional emerging field is the
electronic medical data and
electronic records market
5/21/2013 © Finpro 7
![Page 8: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/8.jpg)
Pharmaceuticals, medical devices and operating
room equipment
5/21/2013 8 © Finpro
98,6
123,9
164,4
220,5
0
50
100
150
200
250
2005 2010 2015 2020
Medical Devices Market in the US, $bn
Source: GlobalData
CAGR
5.5%
![Page 9: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/9.jpg)
Pharmaceutical Market by Segment in the US
5/21/2013 9 © Finpro
247
307
380
471
19 22 27 34
0
100
200
300
400
500
2005 2010 2015 2020
Prescription Drugs OTC Drugs
Pharmaceutical Market by Segment in the US, $bn
CAGR
4.4%*
*Prescription + OTC
![Page 10: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/10.jpg)
Biotechnology
• The US biotechnology revenues formed
ca. 70% of global public biotech
companies’ revenues in 2011
• The decline in revenues of US biotech
companies in 2011 was driven by three
large acquisitions by non-biotech
acquirers – after normalizing for these
acquisitions, the revenues increased by
12%
• In 2011 the US FDA approved more new
drugs than at any time since 2004
• 70% of the approvals were approved in
US before they received approval
anywhere else in the world
• As in prior years, cancer continues to
dominate the US clinical pipeline
• Neurology will become increasingly
important in the years ahead as aging
populations increase the number of
neurodegenerative diseases
5/21/2013 © Finpro 10
![Page 11: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/11.jpg)
The US Clinical Pipeline by Indication
5/21/2013 11 © Finpro
Cancer 44%
Neurology 10%
Infectious disease 9%
Metabolic and endocrine
6%
Autoimmune 4%
Cardiovascular 4%
Respiratory 4%
Other 19%
The US Clinical Pipeline by Indication, 2011
Source: Ernst &Young
![Page 12: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/12.jpg)
Biotechnology revenues in the US
5/21/2013 12 © Finpro
*Publicly traded biotechnology companies in the four established clusters – the United States, Europe, Canada and Australia
Biotechnology revenues in the US and the rest of
the world* (Public company data; USD billion)
61
65,1
56,2
61,1 58,8
19,3 21,7 22,1 23 24,6
0
20
40
60
80
2007 2008 2009 2010 2011
US
ROW*
Source: Ernst &Young
![Page 13: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/13.jpg)
Hospital Equipment and Medical Devices
• US medical device market constitutes 40% of global markets and is
estimated to top $200 billion in 2020
• The biggest segments are the orthopedic devices,
in Vitro Diagnostics (IVD), cardiovascular devices, and ophthalmic
devices
• During 2010-2020 the fastest growing segments are expected to be
the orthopedic devices, IVD, and hospital supplies
• Especially the patient monitoring device market is expected to grow
rapidly in the coming years
• Major drivers are aging population, high healthcare spending, early
diagnosis of diseases, high prevalence of chronic diseases, sedentary
lifestyle of US population, and health tourism
28.3.2013 13 Finpro
![Page 14: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/14.jpg)
Medical Device Market in the US by segment
5/21/2013 14 © Finpro
Orthopedic Devices 16 %
In Vitro Diagnostics 15 %
Cardiovascular Devices
12 % Ophthalmic Devices 10 %
Hospital supplies 6 %
Others 41 %
Medical Device Market in the US by segment, 2010
Source: GlobalData
![Page 15: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/15.jpg)
Medical Device Market in the US
28.3.2013 15 Finpro
98,6
123,9
164,4
220,5
0
50
100
150
200
250
2005 2010 2015 2020
Medical Device Market in the US, $bn
Source: GlobalData
CAGR
5.5%
![Page 16: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/16.jpg)
Healthcare Informatics and Mobile Health
28.3.2013 16 Finpro
• The global mHealth market is expected grow at a CAGR of 41.5% and to reach
$10.2bn by 2018
• US is the largest market for mHealth solutions with a size of $660m or ca. 50% of
the global market
• The monitoring services is the largest and fastest growing mHealth segment
constituting 60% of the total market followed by diagnostic services and healthcare
systems
• Cardiac rhythm management, sleep therapy and ambulatory ECG are the main
monitoring device segments – sleep therapy, blood pressure monitoring, glucose
monitoring and medication adherence are predicted gain more momentum
• Strong growth forecasted for mHealth applications while an additional emerging
field is the electronic records market
• Cloud computing, spread of smartphones, ease of use functionalities, rising health-
care spending, and demand for independent aging solutions and post-acute care
service are driving the growth of mHealth
![Page 17: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/17.jpg)
Healthcare Informatics & Mobile health
5/21/2013 17 © Finpro
$1.3
bn $10.2 bn
Global mHealth market size & segments, $billion
2012 2018
Source: Global Data
80%
Software &
services
12%
Hardware
8%
Networks &
connectivity
![Page 18: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/18.jpg)
Healthcare Informatics & Mobile health
5/21/2013 18 © Finpro
The metric only accounts for devices that use fixed wireless, cellular, and
fixed line connections.
Source: Berg Insight
Connected home medical monitoring devices, million units
(World 2011-2017)
![Page 19: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/19.jpg)
The most important Health & Life Science Clusters in the US
28.3.2013 19 Finpro
Bay Area Life
Science Biotech,
Informatics, VC, Mobile
Los Angeles Biotechnology,
Pharmaceutical,
Medical devices
Seattle R&D, Drug
Development, VC, HIT
New York/
New Jersey/
Philadelphia Pharma, Mobile,
Biotech, Medical
Devices, VC
Boston Biotech,
Pharma, VC, mobile,
devices, HIT
Florida Bioscience, LifeScience,
Medical Devices
Raleigh
Durham, NC Pharma & Biotech
Research, JVs
San Diego Biotechnology ,
Mobile Health IT,
Devices, VC
DC, MD FDA, NIH,I-
270 corridor
”NA Alley”
Atlanta
Bioscience
HIT
Chicago Life Science
Denver: Agriculture, Bioscience
Houston
Research
Indianapolis Life science, implants
Minneapolis Agriculture,
Medical devices
![Page 20: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/20.jpg)
Finpro Gazelle US for Health Science Companies
• A five-stage program, that will take place in Helsinki and US healthcare hubs
• The Bootcamp (4-5.6) facilitator and trainer is Christian Haller
– A trusted advisor and strategist for business executives in the medical technology
and consumer products industries
– Works with executives at start-ups and Fortune 500 companies to conceive, finance,
develop, manufacture and market first of a kind products and new technologies
– A serial internal entrepreneur at MPR, where he has successfully built numerous
new companies
• The program is run by experienced people and gurus from the markets and
industries
• In the US, leading medical experts join the team and work with each company
21/05/2013 20 © Finpro
1 2 5 4 3 Situation
Analysis
Bootcamp Mentoring
&
Coaching
Discovery Entry
Options
![Page 21: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/21.jpg)
Testimonials from Gazelle Bootcamp Graduates 2012
“Absolute must to attend before any business!”
“If thinking of going to the US, do this course!”
“Any start-up should go through this, hands down!”
“It will make you think”
“This session really helps focus your attention on things…”
5/21/2013 21 © Finpro
![Page 22: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/22.jpg)
Financing options
21/05/2013
22 © Finpro
Preliminary Funding Company Development
Grant Joint Purchase Training
Tekes R&D Grant Tekes De minimis grant Tekes Young Innovative
Companies
Go Global Plus
(ELY/Finpro) value17.5 k€,
with approx 75 % support
Finpro Growth Market
Program (TEM/Finpro) value
20 k€ with 50% support
Finnpartnership
Finnvera
Finpro’s programs with funding and financing options
Public financing and funding options
![Page 23: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/23.jpg)
Your contacts in Finland:
Eero Toivainen
Senior Consultant
eero.toivainen(a)finpro.fi
Tel +358 40 343 3379
Kimmo Aura
Regional Sales Manager, Americas
kimmo.aura(a)finpro.fi
Tel +358 40 504 8317
5/21/2013 © Finpro 23
![Page 24: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/24.jpg)
Your contacts in the US:
Val Kratzman
Head of Trade center
val.kratzman(a)finpro.fi
+358 20 4695 806
Maria Mäkelä
Consultant
maria.makela(a)finpro.fi
+358 20 4695 850
5/21/2013 © Finpro 24
![Page 25: Obama care a new opportunity in us healthcare - finpro](https://reader033.fdocuments.us/reader033/viewer/2022051818/54b3efe74a795962108b46c9/html5/thumbnails/25.jpg)
Follow us on social
media and visit our
website www.finpro.fi